Lisa Pirozzolo > WilmerHale > Boston, United States > Lawyer Profile

The intellectual property practice at WilmerHale acts for domestic and international clients, frequently providing innovative solutions spanning trademark, copyright, patent drafting and prosecution, post-grant proceedings, and strategic IP portfolio development. Attorneys in the team have tech transfer and licensing, litigation, and due diligence experience, and also benefit from expertise in the team beyond the United States to other jurisdictions, frequently working with lawyers in the United Kingdom, Germany, and China. The strength of the team is demonstrated through their impressive client list, boasting the likes of Twitter, Sony, Meta Platforms, Hulu, and Bristol-Myers Squibb. Lisa Pirozzolo and Mark Selwyn co-chair the firm’s IP litigation practice, operating out of Boston and Palo Alto respectively, alongside Amy Wigmore, based in Washington DC, where Brittany Amadi is another key lawyer. Emily Whelan in Boston is the chair of the general IP department, focusing on litigation related to chemistry, biotech, and pharma. Boston-based William Lee remains a key figure in the team, with Palo Alto’s Sonal Mehta has vast experience in high-stakes patent and tech disputes.

WilmerHale’s primarily Boston-based team advises a range of clients, including diagnostic and medical device corporates, universities and research institutions, and investment banks. Practice co-chair Stuart Falber advises a range of public life science companies on capital markets related matters, while fellow co-chair Lisa Pirozzolo acts in Hatch-Waxman cases and licensing disputes, often appearing before the ITC and the PTAB. Based in New York, David Bassett has an IP litigation focused practice, and often contends with biotech and pharmaceutical patent disputes alongside Robert Gunther, who also handles trade secret cases before arbitration tribunals. Sarah Hogan focuses on the life sciences and digital health industries, and has a great deal of experience in the negotiation of IP licenses and strategic collaborations.